Citadel Advisors’s JLens 500 Jewish Advocacy U.S. ETF TOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Buy
14,991
+6,168
+70% +$188K ﹤0.01% 9991
2026
Q1
$241K Buy
+8,823
New +$252K ﹤0.01% 10987
2025
Q4
– Sell
-14,663
Closed -$412K – 14564
2025
Q3
$412K Buy
+14,663
New +$396K ﹤0.01% 9596

Other funds holding TOV

Citadel Advisors's TOV Position: Q2 2026 in Review

Citadel Advisors increased its JLens 500 Jewish Advocacy U.S. ETF (TOV) stake by 70% in Q2 2026, buying an estimated $188K and bringing the position to 14,991 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #9991.

Citadel Advisors first reported a position in TOV in Q3 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold TOV as of Q2 2026.

  • Citadel Advisors held 14,991 shares of JLens 500 Jewish Advocacy U.S. ETF worth $472K as of Q2 2026.
  • Citadel Advisors bought 6,168 JLens 500 Jewish Advocacy U.S. ETF shares in Q2 2026, an estimated $188K.
  • JLens 500 Jewish Advocacy U.S. ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9991 holding.
  • Citadel Advisors first reported a position in JLens 500 Jewish Advocacy U.S. ETF in Q3 2025 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held JLens 500 Jewish Advocacy U.S. ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.